Human leukocyte antigen (HLA)-G during pregnancy part II: Associations between maternal and fetal HLA-G genotypes and soluble HLA-G

Human Immunology

Volumn 76, Issue 4, 2015, Pages 260-271

  Dahl, Mette ^a   Klitkou, Louise ^b   Christiansen, Ole B ^b,c   Djurisic, Snezana ^a   Piosik, Zofia Maria ^b   Skovbo, Peter ^b   Møller, Anna Margrethe ^b   Steffensen, Rudi ^b   Hviid, Thomas Vauvert F ^a  

^a Mental Health Center Glostrup   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

HLA G; MHC; Polymorphism; Pregnancy; SHLA G

Indexed keywords

HLA G ANTIGEN; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS; GENETIC ASSOCIATION; GESTATIONAL AGE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; IMMUNOGENETICS; INDEL MUTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL PLASMA; PLACENTA WEIGHT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD; BLOOD; FETUS BLOOD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PREECLAMPSIA; RECURRENT ABORTION;

3' UNTRANSLATED REGIONS; ABORTION, HABITUAL; ALLELES; DNA MUTATIONAL ANALYSIS; FEMALE; FETAL BLOOD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GESTATIONAL AGE; HISTOCOMPATIBILITY; HLA-G ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 84933182336     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.01.015     Document Type: Article

References (70)

1. Goodfellow P.N., Barnstable C.J., Bodmer W.F., Snary D., Crumpton M.J. Expression of HLA system antigens on placenta. Transplantation 1976, 22:595-603.
2. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today 1993, 14:353-356.
3. Ellis S.A., Palmer M.S., McMichael A.J. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J Immunol 1990, 144:731-735.
4. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
5. Redman C.W., McMichael A.J., Stirrat G.M., Sunderland C.A., Ting A. Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. Immunology 1984, 52:457-468.
6. Harrison G.A., Humphrey K.E., Jakobsen I.B., Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993, 2:2200.
7. Larsen M.H., Hylenius S., Andersen A.M., Hviid T.V. The 3'-untranslated region of the HLA-G gene in relation to pre-eclampsia: revisited. Tissue Antigens 2010, 75:253-261.
8. Di Cristofaro J., El Moujally D., Agnel A., Mazieres S., Cortey M., Basire A., et al. HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. Hum Immunol 2013, 74:203-206.
9. Martelli-Palomino G., Pancotto J.A., Muniz Y.C., Mendes-Junior C.T., Castelli E.C., Massaro J.D., et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential HLA-G soluble levels in the Brazilian and French population. PLoS One 2013, 8:e71742.
10. Castelli E.C., Mendes-Junior C.T., Deghaide N.H., de Albuquerque R.S., Muniz Y.C., Simoes R.T., et al. The genetic structure of 3' untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010, 11:134-141.
11. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992, 89:3947-3951.
12. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000, 61:1138-1149.
13. Solier C., Aguerre-Girr M., Lenfant F., Campan A., Berrebi A., Rebmann V., et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002, 32:3576-3586.
14. Morales P.J., Pace J.L., Platt J.S., Langat D.K., Hunt J.S. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007, 122:179-188.
15. Apps R., Gardner L., Sharkey A.M., Holmes N., Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007, 37:1924-1937.
16. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsi V., et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol 2005, 175:4866-4874.
17. Zhong M., Weng X., Liang Z., Lu S., Li J., Chen X., et al. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse. Transplantation 2009, 87:8-15.
18. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003, 171:1376-1384.
19. Hunt J.S., Jadhav L., Chu W., Geraghty D.E., Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am J Obstet Gynecol 2000, 183:682-688.
20. Fuzzi B., Rizzo R., Criscuoli L., Noci I., Melchiorri L., Scarselli B., et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 2002, 32:311-315.
21. Rizzo R., Fuzzi B., Stignani M., Criscuoli L., Melchiorri L., Dabizzi S., et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF?. J Reprod Immunol 2007, 74:133-142.
22. Langat D.K., Sue Platt J., Tawfik O., Fazleabas A.T., Hunt J.S. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006, 71:75-86.
23. Larsen M.H., Bzorek M., Pass M.B., Larsen L.G., Nielsen M.W., Svendsen S.G., et al. Human leukocyte antigen-G in the male reproductive system and in seminal plasma. Mol Hum Reprod 2011, 17:727-738.
24. Rebmann V., Pfeiffer K., Passler M., Ferrone S., Maier S., Weiss E., et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999, 53:14-22.
25. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004, 56:135-141.
26. Plaks V., Rinkenberger J., Dai J., Flannery M., Sund M., Kanasaki K., et al. Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction. Proc Natl Acad Sci U S A 2013, 110:11109-11114.
27. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-1818.
28. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998, 160:3096-3100.
29. Rajagopalan S., Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999, 189:1093-1100.
30. Rizzo R., Vercammen M., van de Velde H., Horn P.A., Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 2011, 68:341-352.
31. Gonzalez A., Rebmann V., LeMaoult J., Horn P.A., Carosella E.D., Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 2012, 49:63-84.
32. Dahl M., Hviid T.V. Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 2012, 18:92-109.
33. Hviid T.V. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006, 12:209-232.
34. Redman C.W. Immunology of preeclampsia. Semin Perinatol 1991, 15:257-262.
35. Hylenius S., Andersen A.M., Melbye M., Hviid T.V. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004, 10:237-246.
36. Iversen A.C., Nguyen O.T., Tommerdal L.F., Eide I.P., Landsem V.M., Acar N., et al. The HLA-G 14bp gene polymorphism and decidual HLA-G 14bp gene expression in pre-eclamptic and normal pregnancies. J Reprod Immunol 2008, 78:158-165.
37. Moreau P., Contu L., Alba F., Lai S., Simoes R., Orru S., et al. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biol Reprod 2008, 79:459-467.
38. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001, 58:1943-1949.
39. Vianna P., Dalmaz C.A., Veit T.D., Tedoldi C., Roisenberg I., Chies J.A. Immunogenetics of pregnancy: role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women. Hum Immunol 2007, 68:668-674.
40. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335-341.
41. Rizzo R., Hviid T.V., Govoni M., Padovan M., Rubini M., Melchiorri L., et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008, 71:520-529.
42. Rizzo R., Hviid T.V., Stignani M., Balboni A., Grappa M.T., Melchiorri L., et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 2005, 57:172-181.
43. Twito T., Joseph J., Mociornita A., Rao V., Ross H., Delgado D.H. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011, 30:778-782.
44. Yie S.M., Taylor R.N., Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005, 193:204-208.
45. Rizzo R., Andersen A.S., Lassen M.R., Sorensen H.C., Bergholt T., Larsen M.H., et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol 2009, 62:320-338.
46. Hackmon R., Koifman A., Hyodo H., Glickman H., Sheiner E., Geraghty D.E. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol 2007, 197(255):e1-e5.
47. Steinborn A., Varkonyi T., Scharf A., Bahlmann F., Klee A., Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 2007, 57:277-286.
48. Yie S.M., Li L.H., Li Y.M., Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004, 191:525-529.
49. Tan Z., Randall G., Fan J., Camoretti-Mercado B., Brockman-Schneider R., Pan L., et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81:829-834.
50. Yie S.M., Li L.H., Xiao R., Librach C.L. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008, 14:649-653.
51. Castelli E.C., Mendes-Junior C.T., Veiga-Castelli L.C., Roger M., Moreau P., Donadi E.A. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011, 28:3069-3086.
52. Djurisic S., Sorensen A.E., Hviid T.V. A fast and easy real-time PCR genotyping method for the HLA-G 14-bp insertion/deletion polymorphism in the 3' untranslated region. Tissue Antigens 2012, 79:186-189.
53. Bortolotti D., Gentili V., Melchiorri L., Rotola A., Rizzo R. An accurate and reliable real time SNP genotyping assay for the HLA-G +3142 bp C>G polymorphism. Tissue Antigens 2012, 80:259-262.
54. Hviid T.V. HLA-G genotype is associated with fetoplacental growth. Hum Immunol 2004, 65:586-593.
55. Sabbagh A., Luisi P., Castelli E.C., Gineau L., Courtin D., Milet J., et al. Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun 2014, 15:95-106.
56. Kramer M.S., Platt R.W., Wen S.W., Joseph K.S., Allen A., Abrahamowicz M., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001, 108:E35.
57. Berger D.S., Hogge W.A., Barmada M.M., Ferrell R.E. Comprehensive analysis of HLA-G: implications for recurrent spontaneous abortion. Reprod Sci 2010, 17:331-338.
58. Hviid T.V., Hylenius S., Hoegh A.M., Kruse C., Christiansen O.B. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002, 60:122-132.
59. Sipak-Szmigiel O., Cybulski C., Lubinski J., Ronin-Walknowska E. HLA-G polymorphism in a Polish population and reproductive failure. Tissue Antigens 2008, 71:67-71.
60. Tripathi P., Abbas A., Naik S., Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004, 64:706-710.
61. Yan W.H., Lin A., Chen X.J., Dai M.Z., Gan L.H., Zhou M.Y., et al. Association of the maternal 14-bp insertion polymorphism in the HLA-G gene in women with recurrent spontaneous abortions. Tissue Antigens 2006, 68:521-523.
62. Zhu Y., Huo Z., Lai J., Li S., Jiao H., Dang J., et al. Case-control study of a HLA-G 14-bp insertion-deletion polymorphism in women with recurrent miscarriages. Scand J Immunol 2010, 71:52-54.
63. Svendsen S.G., Hantash B.M., Zhao L., Faber C., Bzorek M., Nissen M.H., et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region. Hum Immunol 2013, 74:818-827.
64. Rudstein-Svetlicky N., Loewenthal R., Horejsi V., Gazit E. HLA-G levels in serum and plasma. Tissue Antigens 2007, 69(Suppl. 1):140-142.
65. Rizzo R., Trentini A., Bortolotti D., Manfrinato M.C., Rotola A., Castellazzi M., et al. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol Cell Biochem 2013, 381:243-255.
66. Carreiras M., Montagnani S., Layrisse Z. Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection. Am J Reprod Immunol 2002, 48:176-183.
67. Xie F., Hu Y., Magee L.A., Money D.M., Patrick D.M., Krajden M., et al. An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand 2010, 89:1162-1167.
68. Park B., Spooner E., Houser B.L., Stromninger J.L., Ploegh H.L. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 2010, 207:2033-2041.
69. Barel M.T., Ressing M., Pizzato N., van Leeuwen D., Le Bouteiller P., Lenfant F., et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, bu not soluble HLA-G1 for degradation. J Immunol 2003, 171:6757-6765.
70. Jin Z.-K., Xu C.-X., Tian P.-X., Xue W.J., Ding X.-M., Zheng J., et al. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China. Transpl Immunol 2012, 27:69-74.